157 related articles for article (PubMed ID: 26373822)
1. GLUT4 translocation is not impaired after acute exercise in skeletal muscle of women with obesity and polycystic ovary syndrome.
Dantas WS; Marcondes JA; Shinjo SK; Perandini LA; Zambelli VO; Neves WD; Barcellos CR; Rocha MP; Yance Vdos R; Pereira RT; Murai IH; Pinto AL; Roschel H; Gualano B
Obesity (Silver Spring); 2015 Nov; 23(11):2207-15. PubMed ID: 26373822
[TBL] [Abstract][Full Text] [Related]
2. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.
Højlund K
Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125
[TBL] [Abstract][Full Text] [Related]
3. Acute exercise elicits differential expression of insulin resistance genes in the skeletal muscle of patients with polycystic ovary syndrome.
Dantas WS; Murai IH; Perandini LA; Azevedo H; Moreira-Filho CA; Camara NO; Roschel H; Gualano B
Clin Endocrinol (Oxf); 2017 May; 86(5):688-697. PubMed ID: 28177124
[TBL] [Abstract][Full Text] [Related]
4. Intense electroacupuncture normalizes insulin sensitivity, increases muscle GLUT4 content, and improves lipid profile in a rat model of polycystic ovary syndrome.
Johansson J; Feng Y; Shao R; Lönn M; Billig H; Stener-Victorin E
Am J Physiol Endocrinol Metab; 2010 Oct; 299(4):E551-9. PubMed ID: 20663984
[TBL] [Abstract][Full Text] [Related]
5. Lifestyle intervention up-regulates gene and protein levels of molecules involved in insulin signaling in the endometrium of overweight/obese women with polycystic ovary syndrome.
Ujvari D; Hulchiy M; Calaby A; Nybacka Å; Byström B; Hirschberg AL
Hum Reprod; 2014 Jul; 29(7):1526-35. PubMed ID: 24842895
[TBL] [Abstract][Full Text] [Related]
6. Polycystic ovary syndrome is associated with tissue-specific differences in insulin resistance.
Ciaraldi TP; Aroda V; Mudaliar S; Chang RJ; Henry RR
J Clin Endocrinol Metab; 2009 Jan; 94(1):157-63. PubMed ID: 18854391
[TBL] [Abstract][Full Text] [Related]
7. Metformin augments the levels of molecules that regulate the expression of the insulin-dependent glucose transporter GLUT4 in the endometria of hyperinsulinemic PCOS patients.
Carvajal R; Rosas C; Kohan K; Gabler F; Vantman D; Romero C; Vega M
Hum Reprod; 2013 Aug; 28(8):2235-44. PubMed ID: 23595973
[TBL] [Abstract][Full Text] [Related]
8. Impaired insulin-stimulated phosphorylation of Akt and AS160 in skeletal muscle of women with polycystic ovary syndrome is reversed by pioglitazone treatment.
Højlund K; Glintborg D; Andersen NR; Birk JB; Treebak JT; Frøsig C; Beck-Nielsen H; Wojtaszewski JF
Diabetes; 2008 Feb; 57(2):357-66. PubMed ID: 17977950
[TBL] [Abstract][Full Text] [Related]
9. Effects of metformin on the expression of GLUT4 in endometrium of obese women with polycystic ovary syndrome.
Zhai J; Liu CX; Tian ZR; Jiang QH; Sun YP
Biol Reprod; 2012 Aug; 87(2):29. PubMed ID: 22572996
[TBL] [Abstract][Full Text] [Related]
10. Effects of exercise on insulin resistance and body composition in overweight and obese women with and without polycystic ovary syndrome.
Hutchison SK; Stepto NK; Harrison CL; Moran LJ; Strauss BJ; Teede HJ
J Clin Endocrinol Metab; 2011 Jan; 96(1):E48-56. PubMed ID: 20926534
[TBL] [Abstract][Full Text] [Related]
11. Exercise training increases insulin-stimulated glucose disposal and GLUT4 (SLC2A4) protein content in patients with type 2 diabetes.
O'Gorman DJ; Karlsson HK; McQuaid S; Yousif O; Rahman Y; Gasparro D; Glund S; Chibalin AV; Zierath JR; Nolan JJ
Diabetologia; 2006 Dec; 49(12):2983-92. PubMed ID: 17019595
[TBL] [Abstract][Full Text] [Related]
12. Inflammatory cytokines and chemokines, skeletal muscle and polycystic ovary syndrome: effects of pioglitazone and metformin treatment.
Ciaraldi TP; Aroda V; Mudaliar SR; Henry RR
Metabolism; 2013 Nov; 62(11):1587-96. PubMed ID: 23958241
[TBL] [Abstract][Full Text] [Related]
13. Aerobic exercise training improves atrial natriuretic peptide and catecholamine-mediated lipolysis in obese women with polycystic ovary syndrome.
Moro C; Pasarica M; Elkind-Hirsch K; Redman LM
J Clin Endocrinol Metab; 2009 Jul; 94(7):2579-86. PubMed ID: 19366845
[TBL] [Abstract][Full Text] [Related]
14. miRNA-93 inhibits GLUT4 and is overexpressed in adipose tissue of polycystic ovary syndrome patients and women with insulin resistance.
Chen YH; Heneidi S; Lee JM; Layman LC; Stepp DW; Gamboa GM; Chen BS; Chazenbalk G; Azziz R
Diabetes; 2013 Jul; 62(7):2278-86. PubMed ID: 23493574
[TBL] [Abstract][Full Text] [Related]
15. Defects in insulin receptor signaling in vivo in the polycystic ovary syndrome (PCOS).
Dunaif A; Wu X; Lee A; Diamanti-Kandarakis E
Am J Physiol Endocrinol Metab; 2001 Aug; 281(2):E392-9. PubMed ID: 11440917
[TBL] [Abstract][Full Text] [Related]
16. Changes in the expression of insulin signaling pathway molecules in endometria from polycystic ovary syndrome women with or without hyperinsulinemia.
Fornes R; Ormazabal P; Rosas C; Gabler F; Vantman D; Romero C; Vega M
Mol Med; 2010 Mar; 16(3-4):129-36. PubMed ID: 20011249
[TBL] [Abstract][Full Text] [Related]
17. Liraglutide enhances glucose transporter 4 translocation via regulation of AMP-activated protein kinase signaling pathways in mouse skeletal muscle cells.
Li Z; Ni CL; Yao Z; Chen LM; Niu WY
Metabolism; 2014 Aug; 63(8):1022-30. PubMed ID: 24972503
[TBL] [Abstract][Full Text] [Related]
18. Exploring factors related to changes in body composition, insulin sensitivity and aerobic capacity in response to a 12-week exercise intervention in overweight and obese women with and without polycystic ovary syndrome.
Scott D; Harrison CL; Hutchison S; de Courten B; Stepto NK
PLoS One; 2017; 12(8):e0182412. PubMed ID: 28771628
[TBL] [Abstract][Full Text] [Related]
19. AMPK activation by prolonged stimulation with interleukin-1β contributes to the promotion of GLUT4 translocation in skeletal muscle cells.
Takaguri A; Inoue S; Kubo T; Satoh K
Cell Biol Int; 2016 Nov; 40(11):1204-1211. PubMed ID: 27569904
[TBL] [Abstract][Full Text] [Related]
20. Impaired insulin activation and dephosphorylation of glycogen synthase in skeletal muscle of women with polycystic ovary syndrome is reversed by pioglitazone treatment.
Glintborg D; Højlund K; Andersen NR; Hansen BF; Beck-Nielsen H; Wojtaszewski JF
J Clin Endocrinol Metab; 2008 Sep; 93(9):3618-26. PubMed ID: 18544618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
